Around 62% of American households have at least one pet at their home and it is expected to increase further in near future. Various people experience different types of allergies when exposed to the different pets such as dogs, cats, etc. Allergies such as runny nose, sneezing, nasal congestion, itchy eyes, skin rash, etc. are most common type of allergies experienced. Most of the time pet allergy is allergic reaction to saliva, animal’s skin cells, urine, etc. The pet allergy condition ranges from mild to moderately sever such as runny nose to dermatitis. Dead skin of animal is mostly responsible for developing conditions such as eczema, dermatitis, etc. Various diagnostic tests such as skin examination, blood tests, etc. are used to determine the severity of the pet allergy. The incidence of the pet allergy can be decreased significantly by few precautions such as keep the pets out of bedroom, wash the hands after touching pets, limit the where pets can enter, use vacuum and HEPA filter in home to minimize the allergens causing allergy.
Increasing number of households having pets in developed as well as developing countries expected to drive the growth of the pet allergy treatment market. Increasing sensitivity to different type of allergy triggering allergens among the general population expected to drive the growth of the pet allergy treatment market. Various drugs are used for the pet allergy treatment and major manufacturers of these drug have good geographical footprint which offers better revenue generation opportunity in the pet allergy treatment market. Increasing awareness about the possible pet allergies in children as well as adult population further expected to fuel the growth of the pet allergy treatment market. Manufacturers in the pet allergy treatment market are focusing on increasing the awareness through various social platforms in various regions across the globe further expected to fuel the growth of the pet allergy treatment market. Whereas, lower treatment seeking rate in overall allergy cases may hamper the potential growth of the pet allergy treatment market.
Request for Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/28603
The global pet allergy treatment is segmented based on the drug class, allergy type, distribution channel and region.
By drug class, pet allergy treatment market is segmented as:
By allergy type, the global pet allergy treatment market is segmented as:
- Runny nose and Sneezing
By distribution channel, global pet allergy treatment market is segmented as:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online pharmacies
The global pet allergy treatment market is majorly expected to be driven by the increasing number of household having the pets across the world. By drug class, antihistamines expected to be the dominant segment in the global pet allergy treatment market due to higher efficacy in pet allergy treatment compared to other drugs class. By allergy type, runny nose and sneezing expected to be the highest revenue generating segment in pet allergy treatment market due to higher prevalence of the allergy type. By distribution channel, retail pharmacies is expected to be largest revenue generating segment in the global pet allergy treatment market due to higher patient footfall.
If you have any query, ask the analyst @ https://www.persistencemarketresearch.com/ask-an-expert/28603
North America is expected to be the highest revenue generating region in the global pet allergy treatment market due to high number of pets. Europe is expected to be the second most lucrative pet allergy treatment market due to higher incidence of the pet allergy in the region. Latin America pet allergy treatment market is expected to experience the steady growth over the period due to increasing treatment seeking rate. Asia-Pacific is the emerging pet allergy treatment market due to rapidly increasing households with pet in the region. Middle East & Africa is the least lucrative pet allergy treatment market due to least prevalence of the pet allergy.
The key participants operating in the global pet allergy treatment market are: Novartis AG, Pfizer Inc., Boehringer Ingelheim International GmbH, Sanofi, Mylan N.V., Teva Pharmaceutical Industries Ltd. and others